SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Wahlin A) "

Sökning: WFRF:(Wahlin A)

  • Resultat 31-40 av 225
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
31.
  •  
32.
  •  
33.
  •  
34.
  •  
35.
  •  
36.
  •  
37.
  •  
38.
  • Efe, Cumali, et al. (författare)
  • Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis
  • 2018
  • Ingår i: Digestive Diseases and Sciences. - : SPRINGER. - 0163-2116 .- 1573-2568. ; 63:5, s. 1348-1354
  • Tidskriftsartikel (refereegranskat)abstract
    • We studied the efficacy and safety of mycophenolate mofetil (MMF) and tacrolimus as second-line therapy in pediatric patients with autoimmune hepatitis (AIH) who were intolerant or non-responders to standard therapy (corticosteroid and azathioprine). We performed a retrospective study of data from 13 centers in Europe, USA, and Canada. Thirty-eight patients (< 18 years old) who received second-line therapy (18 MMF and 20 tacrolimus), for a median of 72 months (range 8-182) were evaluated. Patients were categorized into two groups: Group 1 (n = 17) were intolerant to corticosteroid or azathioprine, and group 2 (n = 21) were non-responders to standard therapy. Overall complete response rates were similar in patients treated with MMF and tacrolimus (55.6 vs. 65%, p = 0.552). In group 1, MMF and tacrolimus maintained a biochemical remission in 88.9 and 87.5% of patients, respectively (p = 0.929). More patients in group 2 given tacrolimus compared to MMF had a complete response, but the difference was not statistically significant (50.0 vs. 22.2%, p = 0.195). Biochemical remission was achieved in 71.1% (27/38) of patients by tacrolimus and/or MMF. Decompensated cirrhosis was more commonly seen in MMF and/or tacrolimus non-responders than in responders (45.5 vs. 7.4%, p = 0.006). Five patients who received second-line therapy (2 MMF and 3 tacrolimus) developed side effects that led to therapy withdrawal. Long-term therapy with MMF or tacrolimus was generally well tolerated by pediatric patients with AIH. Both MMF and tacrolimus had excellent efficacy in patients intolerant to corticosteroid or azathioprine. Tacrolimus might be more effective than MMF in patients failing previous therapy.
  •  
39.
  •  
40.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 31-40 av 225
Typ av publikation
tidskriftsartikel (155)
konferensbidrag (64)
bokkapitel (2)
recension (2)
annan publikation (1)
forskningsöversikt (1)
visa fler...
visa färre...
Typ av innehåll
refereegranskat (149)
övrigt vetenskapligt/konstnärligt (76)
Författare/redaktör
Wahlin, A (88)
Backman, L (34)
Wahlin, BE (30)
Wahlin, S. (29)
Winblad, B (26)
Wahlin, TBR (16)
visa fler...
Efe, C (14)
Purnak, T (12)
Belada, D (11)
Ozaslan, E (10)
Abbas, A. (9)
Amer-Wahlin, I (9)
Trneny, M (9)
Kimby, E (8)
Fastbom, J (8)
Lehmann, S (7)
Brune, M (7)
Bjorkholm, M (7)
Lundin, A (7)
Hill, RD (7)
Fahlander, K (7)
Muratori, L (7)
Wang, LW (7)
Turesson, I (6)
Harper, P (6)
Fratiglioni, L (6)
Bäckman, Lars (6)
Hoglund, M (6)
Holte, H (6)
Wahlin, Anders (6)
Kwee, A (6)
Christensen, JH (6)
Dixon, RA (6)
Wahlin, B (6)
Lugtenburg, P (6)
Tidefelt, U (5)
Larsson, M (5)
Ljungman, P (5)
Sardh, E (5)
Juliusson, G (5)
Landgren, O (5)
Sander, B (5)
Simonsson, B. (5)
Stenberg, A (5)
Nilsson, LG (5)
Buske, C (5)
Cohen, A (5)
Lytvyak, E (5)
Brochner, AC (5)
Jurczak, W (5)
visa färre...
Lärosäte
Karolinska Institutet (175)
Uppsala universitet (27)
Umeå universitet (19)
Lunds universitet (11)
Göteborgs universitet (8)
Stockholms universitet (7)
visa fler...
Linköpings universitet (7)
Kungliga Tekniska Högskolan (4)
Örebro universitet (4)
Jönköping University (1)
Marie Cederschiöld högskola (1)
visa färre...
Språk
Engelska (223)
Svenska (2)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (34)
Naturvetenskap (6)
Samhällsvetenskap (6)
Teknik (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy